Generic Exclusivity On Delisted Patents Upheld By Appeals Court
This article was originally published in The Pink Sheet Daily
Executive Summary
In ruling on the Zocor case, court finds FDA requirement that a generic company must be involved in patent litigation to retain exclusivity is unlawful.